SCHEMBL8524437

SCHEMBL8524437

Cc1c(C(=O)CCl)ccc2c1CCCC(=O)N2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.38
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
KIF11 P52732 1/20 0.34
GSK3B P49841 2/20 0.34
RAB9A P51151 2/20 0.33
LMNA P02545 2/20 0.33
PKM P14618 1/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
CASP3 P42574 1/20 0.32
CASP2 P42575 1/20 0.32
AKR1C4 P17516 1/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8523943 0.80 ALDH1A1 (0.34) MAPTALDH1A1GSK3BRAB9ALMNA
SCHEMBL16132462 0.76 MAPT (0.46) MAPTALDH1A1KIF11RAB9APKM
SCHEMBL8524839 0.76 MAPT (0.39) MAPTALDH1A1KIF11GSK3BRAB9A
SCHEMBL27076359 0.75 ALDH1A1 (0.37) P2RX7MAPTALDH1A1KIF11MAPK1
SCHEMBL7348087 0.71 NPC1 (0.41) MAPTALDH1A1CASP3CASP2CRBN
SCHEMBL12559746 0.71 TSHR (0.42) MAPTALDH1A1LMNAMEN1TSHR
SCHEMBL9366701 0.69 PKM (0.41) MAPTALDH1A1RAB9APKMSMN1; SMN2
SCHEMBL5467106 0.69 MAPT (0.52) MAPTALDH1A1GSK3BAKR1C4AKR1C3
SCHEMBL16110420 0.67 MAPT (0.43) MAPTALDH1A1KIF11RAB9APKM
SCHEMBL5763044 0.67 ALDH1A1 (0.32) P2RX7MAPTALDH1A1MAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999015524-A1 THIAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-04-01 WO disclosed